| Website | chromatherapeutic... |
| Category | BioTech |
| Phone | 44-(0)1235-829120 |
| pa@chromatherapeu... | |
| Employees | |
| Description | cancer and inflammation treatments |
| TOTAL | $77.5M |
| FUNDING TOTAL | $77.5M |
| Series C, 4/06 Nomura Phase4 Ventures Abingworth Essex Woodlands Health Ventures Gilde Healthcare Partners The Welcom Trust | $53M |
| Venture Round, 6/09 Abingworth Essex Woodlands Health Ventures Gilde IT Fund Wellcome Trust GlaxoSmithKline Nomura Securities | $24.5M |
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. Chroma is the first company to systematically assemble intellectual property in chromatin biology and has established a strong network of academic collaborators. Chroma aims to build substantial shareholder value through the creation of a broad and innovative product pipeline aimed at the treatment of high-prevalence cancers and inflammatory disorders.
